Medicinal chemistry – Page 47
-
ArticleSygnature Discovery
Sygnature Discovery is part of an innovative partnership to bolster the life science sector in Nottingham
-
OpinionUnpicking a clinical trial death
A new study shows up off-target effects of a drug that proved deadly, and highlights the pitfalls of drug discovery
-
FeatureAccess to drugs: a failure of pharma?
Many people around the world are either unable to afford the drugs they need, or their conditions have not been addressed by pharma R&D. Sarah Houlton investigates
-
NewsAnalytical test strip fights fentanyl overdoses
Simple chemical analysis helps drug users prevent overdosing on deadly opioid
-
ResearchModified antibiotic beats superbug resistance
Adding functional groups to vancomycin gives it extra modes of attack against resistant bacteria
-
PodcastFibrin and fibrinogen
From scabby knees to life-threatening strokes, this important protein is the fundamental link in the complex molecular chain that forms blood clots
-
OpinionDrug pricing must be more transparent
Pricing is a complex issue - how can we make it clearer?
-
FeatureDelivering gene therapy
After some well-publicised problems, gene therapy – delivering DNA into people’s cells using viruses – is booming, Anthony King finds
-
OpinionHow safe should drugs be?
What does spotting new risks in approved medicines say about how effective regulators are?
-
BusinessPollution from Indian drugmakers drives drug resistance
Areas around manufacturing sites still heavily contaminated with antimicrobials and breeding multidrug-resistant pathogens
-
PodcastPropranolol hydrochloride
Stave off stage fright with a simple compound that revolutionised drug development
-
NewsIndia's HIV/Aids law may bring relief to a million people
Legislation aims to tackle stigma of testing and treatment
-
ResearchBlue nanoparticles mop up radioactive element
Nanosized Prussian blue formulation removes radioactive caesium from body faster than commercial treatment
-
ResearchHow total synthesis is creating antibiotics
Macrolide synthesis could reinvigorate the antibiotic pipeline
-
ResearchCatalyst puts chiral twist on phosphorus drugs
Simple molecule overcomes headache of phosphorus stereochemistry in antiviral drug synthesis
-
FeatureWearable technology
The future of wearable gadgets will be tiny, flexible, skin-like devices capable of monitoring your health
-
ResearchCrispr enables rapid disease detection
A Crispr enzyme that targets RNA can recognise Zika at minute concentrations
-
Research15-minute test catches out flu virus
A cheap, portable setup to detect influenza viruses could help clinicians prescribe the right drugs
-
FeatureCovalent inhibitor drugs
Exceptions to a long-held rule against chemically bonding to biological targets are powering new cancer medicines, finds Andy Extance
-
NewsNews from the American Chemical Society meeting in San Francisco
News stories from the 253rd National Meeting & Exposition of the American Chemical Society